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Expression of Lipogenic Factors Galectin-12, Resistin,
SREBP-1, and SCD in Human Sebaceous Glands and
Cultured Sebocytes
Wesley J. Harrison1, Jonathan J. Bull2, Holger Seltmann3, Christos C. Zouboulis3,4
and Michael P. Philpott1
The transcription factors CCAAT enhancer-binding protein a, b, and d, and peroxisome proliferator-activated
receptor g are known to be crucial to the differentiation of adipocytes and are expressed in sebaceous gland
cells. As lipogenesis is key to both adipocyte and sebocyte differentiation we hypothesize that sebocytes follow
a similar program of differentiation to adipocytes. We have investigated the expression of known adipogenic
factors resistin, galectin-12, sterol response –element-binding protein–1 (SREBP-1) and stearoyl-CoA desaturase
in the immortalized sebaceous gland cell line SZ95 and whole skin. Reverse transcriptase-PCR analysis showed
the expression of galectin-12, resistin, SREBP-1, and stearoyl-CoA desaturase mRNAs in SZ95 sebocytes.
Immunoreactivity was observed for galectin-12 and SREBP-1 in the nuclei and resistin in the cytoplasm of basal
sebocytes, and stearoyl CoA desaturase in the cytoplasm of basal and luminal sebocytes of human scalp skin.
Expression of galectin-12, resistin, and SREBP-1 in SZ95 sebocytes was confirmed by Western blot analysis. These
data provide further evidence that pathways of differentiation in adipocytes and sebocytes could be similar and
therefore further understanding of sebaceous gland differentiation and lipogenesis and potential therapies for
sebaceous gland disorders may be obtained from our knowledge of adipocyte differentiation.
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INTRODUCTION
The synthesis and accumulation of lipids is a key step in the
differentiation of sebaceous gland cells (Downie and Kealey,
1998; Zouboulis, 2004). The understanding of the differentia-
tion process (including lipogenesis) in sebocytes is not well
defined, particularly when compared with our understanding
of adipocyte differentiation. Two families of transcription
factors have been shown to be crucial for terminal
differentiation of adipocytes. They are the CCAAT enhancer
binding protein (C/EBP) family and the peroxisome proli-
ferator-activated receptor (PPAR) family (MacDougald et al.,
1994; MacDougald and Lane, 1995a, b; Mandrup and Lane,
1997; Lane et al., 1999). C/EBPa has also been shown to have
roles in differentiation and lipogenesis in a range of other
tissues including the liver and alveolar type II cells (Flodby
et al., 1996; Matsusue et al., 2004; Zhang et al., 2004).
PPARg is essential for the differentiation of adipocytes in vivo
and in vitro and C/EBPa has been shown to induce adipocyte
differentiation through transactivation of PPARg (Rosen et al.,
1999, 2002).
C/EBPa, b, and d have been detected in human sebaceous
glands (Bull et al., 2002), as well as in cultured human
sebocytes along with PPARg (Chen et al., 2003). From in vitro
stimulation studies using PPAR agonists, PPARg has been
proposed to have a role in the control of differentiation and
lipogenesis in sebocyte-like cells of rat preputial glands
(Rosenfield et al., 1998), isolated human sebaceous glands
(Downie et al., 2004), and cultured human sebocytes (Alestas
et al., 2006). Because the C/EBP and PPAR families are
important in adipocyte differentiation, their expression in
sebaceous glands suggests that differentiation of sebocytes
and production of sebum may mimic that of adipocytes.
In this study, we have investigated whether other specific
markers of adipocyte differentiation are expressed in human
sebaceous glands and cultured sebocytes. The adipogenic
factors resistin, galectin-12, sterol response element-binding
protein-1 (SREBP-1), and stearoyl CoA desaturase (SCD) are,
indeed, expressed in human scalp sebaceous glands and in
the immortalized sebaceous gland cell line SZ95. These data
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provide further evidence that suggests the pathway of
differentiation in sebocytes could be similar to adipocytes.
Therefore, further understanding of sebaceous gland diffe-
rentiation and lipogenesis and possible therapies for seba-
ceous gland disorders may be obtained from our knowledge
of adipocyte differentiation.
RESULTS
Expression of galectin-12, resistin, SREBP-1a, SREBP-1c, and
SCD mRNA in whole human skin primary keratinocytes and
SZ95 sebocytes
Reverse transcriptase-PCR (RT-PCR) analysis showed the
expression of galectin-12, resistin, SREBP-1a and c, and
SCD mRNA in whole human skin, the SZ95-immortalized
sebaceous gland cell line as well as human pre-adipocytes. In
N/TERT keratinocytes, only SREBP-1a and SCD mRNAs were
detected (Figure 1).
C/EBPa, galectin-12, resistin, SREBP-1, and SCD
immunoreactivity is restricted to specific compartments of
human scalp skin
The distribution of C/EBPa, galectin-12, resistin, SREBP-1,
and SCD in human scalp skin was investigated by immuno-
histochemistry and is shown in Figure 2 and summarized in
Table 1. The pattern of immunoreactivity for C/EBPa (Figure
2a–c) has previously been reported by us with intense nuclear
immunolocalization in sebaceous gland cells (Figure 2c) and
cytoplasmic and nuclear immunoreactivity in all layers of the
epidermis (Figure 2b) and outer root sheath (ORS) of the hair
follicle. The localization of galectin-12 immunoreactivity is
shown in Figure 2d–f. Strong immunoreactivity was observed
in the nucleus and cytoplasm of basal cells within the ORS
with weaker cytoplasmic immunoreactivity in the suprabasal
cells (Figure 2d). In the epidermis, weak cytoplasmic
immunoreactivity was observed in the basal keratinocytes
whereas in the suprabasal keratinocytes cytoplasmic immuno-
reactivity for galectin-12 was much stronger (Figure 2e). In
the sebaceous gland, nuclear immunolocalization was
observed in the basal sebocytes, whereas weaker cytoplasmic
immunoreactivity was observed in the luminal sebaceous
gland cells (Figure 2f). The pattern of resistin immunoreacti-
vity is shown in Figure 2g–i. Resistin immunolocalization was
observed predominantly in the cytoplasm of the ORS and
epidermal keratinocytes (Figure 2g and h). Resistin immuno-
reactivity was also observed in the sebaceous glands (Figure
2i) with higher intensity immunolocalization in the cytoplasm
of the basal cells. The pattern of SREBP-1 immunoreactivity is
shown in Figure 2j–l. SREBP-1 immunoreactivity was
observed in the ORS, epidermis, and sebaceous gland. The
immunoreactivity observed in the ORS appeared more
intense in the upper parts of the hair follicle/infundibulum
than in the ORS below the sebaceous duct (Figure 2j). In the
epidermis, SREBP-1 immunoreactivity appeared strongest in
the suprabasal keratinocytes, where it appeared to have peri-
nuclear localization. In the basal keratinocytes, the immu-
noreactivity was less intense and restricted to the cytoplasm
(Figure 2k). SREBP-1 immunolocalization in the sebaceous
gland was observed in the cytoplasm and nucleus of the basal
but not in the luminal sebaceous gland cells (Figure 2l). The
pattern of immunoreactivity for SCD is shown in Figure 2m–o.
SCD immunoreactivity was detected in the sebaceous glands
and in the ORS and epidermis (Figure 2m). In the epidermis,
SCD was detected in all layers; however, only low-intensity
cytoplasmic immunolocalization was observed (Figure 2n). In
contrast, intense immunoreactivity for SCD was observed in
the sebaceous glands, where immunolocalization of SCD was
detected in the cytoplasm of both basal and luminal
sebaceous gland cells (Figure 2o).
Immunocytochemistry confirms expression of galectin-12,
resistin, SREBP-1, and SCD in cultured sebocytes
To confirm expression of galectin-12, resistin, SREBP-1, and
SCD within specific cell types, immunocytochemistry was
carried out on cultured SZ95 sebocytes and N/TERT
keratinocytes. Immunocytochemistry of cultured SZ95 sebo-
cytes showed immunolocalization of C/EBPa within the
nuclei and cytoplasm (Figure 3). Galectin-12, resistin,
SREBP-1, and SCD immunolocalization was predominantly
cytoplasmic with resistin and SCD immunostaining more
intense than that of galectin-12 and SREBP-1 (Figure 3). No
immunoreactivity for galectin-12, resistin, or SCD was
detected in N/TERT keratinocytes and only low levels of
SREBP-1 immunolocalization detected in the cytoplasm (data
not shown).
Western blot analysis confirms expression of galectin-12,
resistin, SREBP-1, and SCD in human skin and cultured
sebocytes
Using the same antibodies as used for immunohistochemistry
and immunocytochemistry, Western blot analysis of whole
skin as well as whole lysates from SZ95 sebocytes, pre-
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Figure 1. RT-PCR analysis. RT-PCR analysis of galectin-12, resistin, SREBP-1a,
SREBP-1c, and SCD in human SZ95 sebocytes, pre-adipocytes, N/TERT
keratinocytes, and whole human skin. Agarose/ethidium bromide gel analysis
of RT-PCR amplicons of galectin-12, resistin, SREBP-1a, SREBP-1c, and SCD
in total RNA extracts from human SZ95 sebocytes, pre-adipocytes, N/TERT
keratinocytes, and whole human skin (n¼ 3).
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adipocytes, and N/TERT keratinocytes showed the expression
of C/EBPa, resistin, galectin-12, SREBP-1 precursor, and SCD
at their predicted molecular weights (Figure 4). In SZ95
sebocyte lysates, C/EBPa (42 kDa), galectin-12, resistin,
SREBP-1 precursor, and SCD were all detected, correspond-
ing with the RT-PCR, immunohistochemistry, and immuno-
cytochemistry data. In human pre-adipocytes, galectin-12,
resistin, and low levels of SREBP-1 precursor were detected.
SCD was not, however, detected in pre-adipocyte lysates,
which contrasts with the RT-PCR results that also showed
SCD mRNA expression in pre-adipocytes. In N/TERT
keratinocyte lysates, C/EBPa and SREBP-1 precursor were
detected but not galectin-12, resistin, or SCD. In whole skin
lysate, C/EBPa, galectin-12, and SCD were detected by
Western blot but not resistin or SREBP-1. These observations
do not correspond to the RT-PCR and immunohistochemistry
data that show detection of mRNA and immunoreactivity for
galectin-12, resistin, SREBP-1, and SCD in whole skin.
Resistin and SCD are not regulated by C/EBPa in the
immortalized sebaceous gland cell line SZ95
To determine whether resistin, SCD, PPARg, or involucrin
expression in sebocytes is regulated by C/EBPa, we transi-
ently transfected SZ95 sebocytes with pCMV-C/EBPa. Over-
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Figure 2. Immunohistochemical analysis reveals that C/EBPa, galectin-12, resistin, SREBP-1, and SCD are located within specific cell populations in human
scalp skin. Immunoreactivity in the distal human hair follicle is shown for (a) C/EBPa, (d) galectin-12, (g) resistin, (j) SREBP-1, and (m) SCD. Immunoreactivity
in the interfollicular epidermis is shown for (b) C/EBPa, (e) galectin-12, (h) resistin, (k) SREBP-1, and (n) SCD. Immunoreactivity in the sebaceous gland is
shown for (c) C/EBPa, (f) galectin-12, (i) resistin, (l) SREBP-1, and (o) SCD. (p–r) Absence of specific immunolocalization observed when the primary antibody
is pre-incubated with a specific blocking peptide. Bars¼ (a, d, g, j, m, p) 200mm; (b, e, h, k, n, q) 50 mm; (c, f, i, l, o, r) 100 mm, (n¼6). Immunolocalization
for all samples is summarized in Table 2.
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expression of C/EBPa in SZ95 sebocytes was confirmed by
Western blot (Figure 5). However, no changes in expression
of resistin, SCD, PPARg, or involucrin were observed
(Figure 5).
DISCUSSION
We have detected the expression of galectin-12, resistin,
SREBP-1, and SCD in sebaceous glands of human scalp skin
by immunohistochemistry and in the immortalized sebaceous
gland cell line SZ95 by RT-PCR, immunocytochemistry, and
Western blot. These proteins are all involved in adipocyte
differentiation and to the best of our knowledge only
expression of SCD has previously been reported in human
sebocytes before this study (Georgel et al., 2005). The
detection of these adipogenic factors in human sebaceous
glands suggests that they may play a similar role in sebocyte
differentiation to those in adipocyte differentiation.
Galectin-12 is a b-galactoside-binding protein that is
involved in both adipocyte cell cycle regulation and terminal
differentiation (Hotta et al., 2001; Yang et al., 2001, 2004). In
mouse pre-adipocytes, galectin-12 is upregulated and initi-
ates G1 arrest (Yang et al., 2001). Moreover, upregulation of
galectin-12 and initiation of G1 arrest is associated with pre-
adipocytes acquiring competence to undergo terminal
differentiation (Yang et al., 2004). Knockdown of endogenous
galectin-12 in mouse 3T3-L1 cells by siRNA resulted in the
failure of these cells to differentiate in response to adipogenic
hormone treatment (Yang et al., 2001). Our observation that
galectin-12 is localized in the nuclei and cytoplasm of the
basal sebaceous gland cells is consistent with galectin-12’s
dual role as initiator of cell-cycle arrest and of terminal
differentiation. In adipocytes, downstream targets of galectin-
12 include C/EBPa, C/EBPb, and PPARg (Yang et al., 2004). If
galectin-12 is also upstream of these factors in sebocytes this
may explain why no change was detected in galectin-12 level
in response to C/EBPa (data not shown).
Lipid synthesis and accumulation is a major part of sebo-
cyte differentiation (Downie and Kealey, 1998; Zouboulis,
2004). SCD is a rate-limiting enzyme in the monounsa-
turated fatty acid biosynthesis pathway where it preferably
oxidizes palmitoyl-CoA and stearoyl-CoA to palmitoleoyl-
CoA and oleoyl-CoA, respectively (Miyazaki et al., 2001).
These monounsaturated fatty acids are substrates for the
synthesis of phospholipids, triglycerides, cholesteryl esters,
and wax esters components of sebum (Greene et al., 1970;
Stewart et al., 1978). The SCD promoter region also contains
a C/EBPa-binding domain suggesting C/EBPa may be
involved in its transcription regulation. SCD has been shown
to be expressed in mouse sebaceous gland (Parimoo et al.,
1999; Zheng et al., 1999) and in SZ95 sebocytes (Georgel
et al., 2005). Here, we confirm the detection of SCD at
transcript and protein level in SZ95 sebocytes and by
immunohistochemistry in human sebaceous glands. The
cytoplasmic immunolocalization of SCD is consistent with
its role in lipogenesis. Although the SCD promoter region
contains a C/EBPa-binding domain, our C/EBPa overexpres-
sion data showed no transactivation of SCD in SZ95
sebocytes. This lack of activation may be because the
expression of SCD was already maximal or may indicate
that other transcription factors such as SREBP-1 are more
important regulators of SCD in SZ95 sebocytes. The expres-
sion of SCD has been shown to be controlled in mouse
adipocytes by sterol levels through the transcription factors
SREBP-la, lc, and 2, which bind the sterol response element
(Brown and Goldstein, 1997; Tabor et al., 1998, 1999;
Shimano et al., 1999; Shimano, 2001) and this may also
apply in sebocytes.
The SREBP transcription factors are important regulators of
lipid synthesis and cholesterol homeostasis. SREBP-1 has
been detected in hamster ear sebocytes and implicated in the
mode of action of androgens in increasing proliferation and
differentiation (Rosignoli et al., 2003). Here, we report the
Table 1. Primer sequences, predicted amplicon size, and specific annealing temperatures used for RT-PCR
Gene Primer sequence Annealing temperature (1C) Amplicon size (bp)
C/EBPa 50primer 50-GAAAGCTAGGTCGTGGGTCA-30 55 193
30primer 50-TCATAACTCCGGTCCCTCTG-30
Galectin-12 50primer 50-AGGTGCCCTGCTCACATGCTC-30 57 391
30primer 50-CCATCCTTCAGGAGTGGACACAG-3
Resistin 50primer 50-TCTAGCAAGACCCTGTGCTCCA-30 59 479
30primer 50-CTCAGGGCTGCACACGACAG-30
SREBP-1a 50primer 50-CTGCTGACCGACATCGAAGAC-30 62 321
30primer 50-GATGCTCAGTGGCACTGACTCTTC-30
SREBP-1c 50primer 50-CGGAGCCATGGATTGCACTTTC-30 62 328
30primer 50-GATGCTCAGTGGCACTGACTCTCC-30
SCD 50primer 50-AACAGTGCTGCCCACCTCTT-30 57 298
30primer 50-GACCCCAAACTCAGCCACTC-30
C/EBP, CCAAT enhancer binding protein; SCD, stearoyl CoA desaturase; SREBP-1, sterol response element-binding protein-1.
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immunolocalization of SREBP-1 in the sebaceous gland,
predominantly in the nucleus of basal sebocytes but lower in
luminal sebocytes. RT-PCR analysis showed the expression of
both the SREBP-1a and SREBP-1c transcripts in SZ95
sebocytes. The antibody used against SREBP-1 detects both
the SREBP-1a and 1c isoforms. In SZ95 sebocytes, the
125 kDa precursor form of SREBP-1a was the predominant
isoform detected with low levels of the 115 kDa SREBP-1c
isoform precursor also being found. However, neither of the
transcriptionally active isoforms was detected by Western
blotting. On the other hand, the nuclear immunolocalization
detected by immunohistochemistry suggests that the active
isoform is expressed in vivo, as only the active isoform can
translocate to the nucleus (Wang et al., 1994).
Resistin, a novel cysteine-rich protein secreted by adipo-
cytes, is considered to exhibit a role in adipocyte differentia-
tion (Kim et al., 2001), regulation of fatty acid uptake and
metabolism (Palanivel and Sweeney, 2005) and proliferation
in human pre-adipocytes (Ort et al., 2005) and smooth
muscle cells (Calabro et al., 2004). C/EBPa has been shown to
bind to the proximal-promoter region of the resistin gene and
promote transcription by recruitment of co-activators p300
and CERB-binding protein in mouse 3T3-L1 adipocytes
(Hartman et al., 2002). The human resistin promoter region
has only 49.8% sequence identity with mouse but the sterol
response elements and C/EBPa-binding site are well con-
served. Seo et al. (2003) have reported that C/EBPa and
SREBP1c bind directly to the human resistin promoter region
and initiate transactivation; however, C/EBPa and SREBP1c
appear to operate independently suggesting that both
transcription factors play a role in control of resistin
expression (Seo et al., 2003). Resistin expression has been
detected at mRNA level in bone marrow, lung, and skeletal
muscle but its expression does not seem to have been
investigated in skin (Ort et al., 2005). We have detected
resistin throughout the sebaceous gland by immunohisto-
chemistry with the strongest immunolocalization in the basal
sebaceous gland cells. In cultured SZ95 sebocytes, resistin
expression was detected at both mRNA and protein levels.
42 kDa
32.5 kDa
12.5 kDa
125 kDa
115 kDa
68 kDa
37 kDa
37 kDa
C/EBP
Galectin-12
Resistin
SREBP-1
SCD
GAPDH
SZ
95
 s
eb
oc
yt
es
Pr
e-
ad
ip
oc
yt
es
W
ho
le
 s
ki
n
N
 / T
ER
T 
ke
ra
tin
oc
yt
es
Figure 4. Western blot analysis. Western blot analysis shows the pattern of
expression of C/EBPa, galectin-12, resistin, SREBP-1, and SCD in SZ95
sebocytes, pre-adipocytes, N/TERT keratinocytes, and whole skin lysates.
Using the same antibodies used for immunohistochemistry and
immunocytochemistry C/EBPa, galectin-12, resistin, SREBP-1, and SCD
isoforms were detected in SZ95 sebocytes, human pre-adipocytes, N/TERT
keratinocytes, and whole skin lysates. Glyceraldehyde-3-phosphate
dehydrogenase was detected to indicate equal protein loading (n¼ 6).
a b
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Figure 3. Immunocytochemical analysis. Immunocytochemical analysis
reveals subcellular localization of C/EBPa, galectin-12, resistin, SREBP-1, and
SCD in cultured human SZ95 sebocytes. Immunocytostaining of SZ95
sebocytes with (a) anti-C/EBPa, (b) anti-galectin, (c) anti-resistin, (d) anti-
SREBP-1, (e) anti-SCD antibodies as used for immunohistochemistry, and
(f) absence of specific immunolocalisation observed when the primary
antibody is pre-incubated with a specific blocking peptide (n¼6).
Bar¼50 mm.
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These results suggest that resistin plays a role in the control of
sebocyte proliferation and differentiation. The expression of
resistin in the basal sebocytes correlates with the proposal
that resistin prevents differentiation in adipocytes as the basal
cells are proliferative rather than differentiating. However,
the expression of resistin in the differentiated luminal
sebocytes was not expected; it is possible that these cells
produce resistin but are not the target for its action or that
resistin has another function in differentiated sebocytes
possibly associated with its reported proinflammatory func-
tion (Calabro et al., 2004). C/EBPa is known to activate
adipocyte differentiation in the 3T3-L1 cell line (Lin and
Lane, 1994). In this study, overexpression of C/EBPa had no
effect on levels of expression of SREBP-1, SCD, resistin, and
galectin-12. Although the reasons for this are not clear, we
have shown by immunohistochemistry that these markers are
predominantly expressed in basal sebocytes of sebaceous
glands. The SZ95 sebocyte cell line probably reflects a more
differentiated population of cells than those found in the
basal layer of the sebaceous gland and may have already
been stimulated to undergo lipogenesis. To verify whether
these genes are directly controlled by C/EBPa would require
culture of basal sebocytes and direct transfection of C/EBPa
into these cells using retrovirus. These experiments would
represent a significant problem however, as it would be
difficult to generate enough basal undifferentiated sebocytes
by explant culture to carry them out.
The expression of galectin-12, resistin, and SREBP-1 in
keratinocytes may also be responsible for lipogenesis, as
keratinocytes secrete lipids as part of the barrier formation
process. It should also be noted that C/EBPs (Bull et al., 2002)
and PPARs (Trivedi et al., 2006) are also expressed in
epidermal keratinocytes although they also have a well-
established or proposed role in adipocyte/sebocyte differ-
entiation. These data point to the shared lineage of
keratinocytes and sebocytes (Niemann et al., 2003).
The expression of C/EBPa, SREBP-1, SCD, resistin, and
galectin-12 within the sebaceous gland provides further
evidence that sebaceous gland differentiation may correlate
with adipocyte differentiation. Further, our data showing that
these factors are also expressed in the immortalized seba-
ceous gland cell line SZ95 suggest that these cells could be a
useful model system to examine the functions of SREBP-1,
resistin, and galectin-12 in human sebocyte differentiation.
However, our observation that overexpression of C/EBPa had
no effect on expression of these factors may indicate that they
are upstream of C/EBPa, for example, galectin-12 or under
control of other regulatory factors. These and the mechanisms
of action of C/EBPa, SREBP-1, SCD, resistin, and galectin-12
in sebocytes remain to be elucidated. Loss-of-function studies
for each factor should be carried out in future studies to
determine whether they are involved in differentiation.
Nevertheless, the data presented here further support the
hypothesis that adipocyte and sebocyte differentiation may
correlate and that the availability of sebaceous gland cell
lines, such as SZ95 (Zouboulis et al., 1999) and SEB-1
(Thiboutot et al., 2003) along with the detailed literature
pertaining to adipocyte differentiation should allow signi-
ficant advances in understanding sebocyte differentiation.
MATERIALS AND METHODS
The medical ethics committee of Queen Mary, University of London
approved all described studies.
Tissue preparation
Experiments were carried out on redundant hair-bearing human
scalp skin, obtained with written informed consent from patients
undergoing facelift operations (ethical committee permission was
provided and experiments were in adherence with the Declaration
of Helsinki Principles). Upon removal, small pieces of skin
(approximately 1.0 cm2) were either snap-frozen in liquid nitrogen
or minced for preparation of RNA extracts or protein lysates. Frozen
skin pieces were later mounted in Cryo-M-Bed (Bright Instruments,
Cambridge, UK) and 6-mm thick sections cut on a cryostat at 251C.
Sections were thaw-mounted onto PolysineTM slides (VWR Inter-
national, Poole, UK) and air-dried for 30 minutes before storage at
801C until required.
Immunohistochemistry
Frozen sections were fixed in acetone:methanol (1:1 v/v) for
15 minutes, endogenous peroxidase activity blocked by treatment
with 0.3% H2O2:methanol (v/v) for 15 minutes and nonspecific
staining blocked with 0.1% BSA (w/v) in tris-buffered saline (TBS) for
30 minutes. Antibodies raised against C/EBPa (rabbit polyclonal,
14AA), resistin (rabbit polyclonal, H-70), SCD (goat polyclonal,
N-20), and SREBP-1 (mouse monoclonal, E4) (all from Santa Cruz
Biotechnology, Santa Cruz, CA) and galectin-12 (rabbit polyclonal)
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Figure 5. Western blot analysis shows that the overexpression of C/EBPa
does not increase the expression of resistin, SCD, PPARc, or involucrin.
Increased expression of 42 and 30 kDa C/EBPa isoforms detected in SZ95
sebocytes transfected with pCMV-C/EBPa (lane 3) and 30 kDa isoform in SZ95
sebocytes transfected with pCMV-30 kDa (lane 4), compared with
untransfected (lane 1) or pCMV-STOP-transfected (lane 2) SZ95 sebocytes.
No changes in expression level were detected for resistin, SCD, PPARg, or
involucrin (n¼ 3).
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(Zymed Labs, San Francisco, CA) were diluted 1:100 in 0.1% BSA
and incubated for 90 minutes at room temperature. Sections
were washed for 15 minutes in three changes of phosphate-buffered
saline (PBS). Secondary and tertiary antibodies from Vectastain ABC
Elite kits universal and goat (Vector Laboratories, Peterborough, UK)
were used in accordance with the manufacturer’s instructions.
Immunolocalization was visualized with 3,30-diaminobenzidine
tetrahydrochloride solution (BioGenex, San Ramon, CA) and
sections mounted in DePeX mountant (BDH Laboratory Supplies,
Poole, UK).
Cell culture
The immortalized sebaceous gland cell line SZ95 (Zouboulis et al.,
1999) was grown in DMEM:F12 (1:1) Glutmax (Invitrogen, Paisley,
UK) supplemented with 10% heat-inactivated fetal calf serum
(Invitrogen), 5 ng/ml human recombinant epidermal growth factor
(Sigma-Aldrich, Dorset, UK), and 50 mg/ml gentamycin (Invitrogen).
N/TERT keratinocytes were cultured in DMEM:F12 (3:1) supple-
mented with 10% foetal calf serum (Biowest, Nuaille, France),
10 ng/ml epidermal growth factor, 5mg/ml insulin, 0.4 mg/ml hydro-
cortisone, and 1010 M cholera toxin (all from Sigma-Aldrich,
Dorset, UK). Human subcutaneous pre-adipocytes (a kind gift from
Professor Marie-Francoise Harmond) were grown in DMEM:F12
(3:1) supplemented with 10% foetal calf serum (Biowest) and
1% glutamine.
RT-PCR
Total RNA was extracted from cultured cells and minced whole skin
using a Qiagen kit (Qiagen, Crawley, West Sussex, UK) and treated
with DNase (Qiagen). After denaturation at 651C for 10 minutes,
2.5 mg of RNA was reverse transcribed at 371C for 1 hour using a first
strand cDNA synthesis kit containing pd(N)6 random hexade-
oxynucleotides and NotI-d(T)18 primers and murine reverse
transcriptase (GE Healthcare formerly Amersham Biosciences, Little
Chalfont, Bucks, UK). The primers used for PCR are listed in Table 2,
all were synthesized by MWG biotech (MWG Biotech AG,
Ebersberg, Germany). PCR amplification of 2ml cDNA in 25 ml
reaction buffer containing 1 U Taq polymerase (GE Healthcare),
20 pmol of 50 and 30 primers and dATP, dCTP, dGTP, dTTP each at
5 nmol. The thermal cycles used were; initial heating at 941C for
3 minutes, followed by 35 cycles of 941C for 30 seconds, variable
annealing temperatures (Table 1) for 30 seconds, and extension at
721C for 45 seconds followed by 721C for 10 minutes. The thermal
cycling was performed in a Hybaid MBS 0.2S thermal cycler
(Hybaid, Middlesex, UK). Amplicons were run on a 1.6% agarose
gel with 1mg/ml ethidium bromide.
SDS-PAGE and Western blot analysis
Whole-cell lysates were prepared from cultured cells and minced
skin using cell lysis buffer (Promega, Southampton, UK). Under
reducing conditions, 10 mg of lysates were denatured by boiling for
5 minutes and run on a 10 or 12% polyacrylamide gel. The proteins
were transferred to polyvinylidene membrane (GE Healthcare), the
membrane blots were probed with the same antibodies used for
immunohistochemistry and anti-PPARg (rabbit polyclonal) (Cell
Signalling Technology, Danvers, MA), anti-involucrin (CRUK,
London, UK) and glyceraldehyde-3-phosphate dehydrogenase
(Abcam, Cambridge, UK) diluted according to the manufacturers’
instructions. The primary antibodies were detected using horse-
radish peroxidase-conjugated anti-rabbit, -goat, or -mouse IgG
antibodies (1:1,000) (Dako, Cambridge, UK) and visualized with
enhanced chemiluminescence (ECLþWestern blotting detection kit)
(GE Healthcare), followed by exposure to Hyperfilm ECL (GE
Healthcare).
Immunocytochemistry
SZ95 sebocytes were grown on glass coverslips 22 22 mm (VWR
International) until 70% confluent, washed three times with TBS,
then fixed in 0.3% (v/v) H2O2 in methanol for 15 minutes and
permiablized with 0.1% (v/v) Triton X-100 (Sigma-Aldrich) in TBS for
15 minutes. Nonspecific binding was blocked with 10% (v/v) horse
or rabbit serum in TBS for 20 minutes. Primary antibodies (as used for
immunohistochemistry) were diluted in 0.1% (w/v) BSA in TBS and
incubated at room temperature for 90 minutes. Secondary and
tertiary antibodies from Vectastain ABC Elite kits (universal and goat)
(Vector Laboratories, Peterborough, UK) were used in accordance
with the manufacturer’s instructions with three times 5-minutes TBS
washes after each incubation. Immunolocalization was visualized
with 3,30-diaminobenzidine tetrahydrochloride solution (BioGenex)
and coverslips mounted in DePeX mountant (BDH Laboratory
Supplies, Poole, UK).
C/EBPa overexpression
SZ95 sebocytes were transiently transfected with pCMV-C/EBPa,
pCMV-30 kDa, or pCMV-STOP constructs (generously supplied by
Dr Thurl Harris, Huffington Centre on Ageing, Baylor College of
Medicine, Houston, TX) by calcium phosphate precipitation; briefly,
1mg DNA made up to 45 ml with dH2O, 5 ml of 2.5 M CaCl2 was
added drop-wise followed by 50 ml of 2N-2-hydroxyethylpiper-
azine-N0-2-ethanesulfonic (HEPES)-buffered saline (280 mM NaCl,
50 mM HEPES, 1.5 mM Na2HPO4, pH 7.12) incubated for 30 minutes.
Transfection mix added to monolayer (1 105 cells) and incubated
for 5 hours. Monolayer washed with versene followed by PBS and
shocked with 20% (v/v) glycerol in PBS for 1 minute then washed
three times with medium. The vectors have been described
previously (Hendricks-Taylor and Darlington, 1995).
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Table 2. Summary of Galectin-12, resistin, SREBP-1,
and SCD immunoreactivity patterns in human scalp
skin
Factor SG ORS Epidermis Dermis
Galectin-12 +++ +++ ++ 
Resistin ++ +++ +++ 
SREBP-1 ++ ++ ++ 
SCD +++ + + 
ORS, outer root sheath; SG, sebaceous gland; SCD, stearoyl CoA
desaturase; SREBP-1, sterol response element-binding protein-1; , no
detectable immunoreactivity; +, low-intensity immunoreactivity; ++,
higher intensity immunoreactivity, +++, strong immunoreactivity.
A summary of relative immunoreactivity intensity detected by immuno-
histochemistry in specific compartments of hair-bearing skin. Three
different skin samples were analyzed (n=6).
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